Beijing Tiantan Biologic. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Tiantan Biologic. with three other
companies in this sector in China:
China Biologic Products, Inc.
sales of 1.86 billion Chinese Renmimbi [US$276.66 million]
of which 100%
was Human Blood Product),
Hualan Biological EngineeringInc
(1.47 billion Chinese Renmimbi [US$218.20 million]
of which 92%
was Blood Product), and
Tonghua Dongbao Medicines Company Limited
(1.67 billion Chinese Renmimbi [US$247.47 million]
of which 97%
Beijing Tiantan Biologic. reported sales of 1.62 billion Chinese Renmimbi (US$240.02 million)
December of 2015.
decrease of 11.4%
versus 2014, when the company's sales were 1.83 billion Chinese Renmimbi.